Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.89
Bid: 0.86
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.06 (6.977%)
Open: 0.89
High: 0.89
Low: 0.89
Prev. Close: 0.89
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tender Offer

10 Nov 2011 09:41

RNS Number : 8545R
J.P. Morgan Private Equity Ltd
10 November 2011
 



 

J.P. MORGAN PRIVATE EQUITY LIMITEDANNOUNCES INTENT TO OPERATE TENDER FACILITY FOR THE PERIODENDING 31 DECEMBER 2011

 

* * *

 

GUERNSEY, 10 NOVEMBER 2011

 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company") is pleased to announce its intent to make a tender offer to purchase up to 3% of US$ Equity Shares, 2013 ZDP Shares and 2015 ZDP Shares, respectively, currently in issue (excluding shares held in treasury) (the "Shares").

 

JPEL's Board of Directors intends to make a formal announcement regarding the operation of the Company's tender facility in due course. Shares will be tendered based on the prevailing net asset value (NAV) as at 31 December 2011.

 

"Returning capital to shareholders at prevailing NAV is a significant priority and is a direct result of the Company's strong balance sheet and distribution activity." said Trevor Ash, JPEL's Chairman. "When distribution activity is sufficient, we look to reward shareholders with the ability to periodically tender shares at NAV. JPEL is the only listed private equity fund to offer such a tender facility. Since its IPO in 2005, JPEL has returned over $127 million to shareholders through redemptions, tenders and market buy backs."

 

The terms and conditions of the tender offer and instructions on how shareholders may participate in the tender offer will be set forth in a Circular to be published once the Company makes a formal announcement. The Company will hold Shares tendered in treasury, subject to compliance with all regulatory limits. At this time, no tender will be made for 2017 ZDP Shares as there is currently no shareholder authority for the Company to tender 2017 ZDP Shares. JPEL intends to seek the authority to tender up to 15 per cent. of all classes of shares currently in issue at the Company's next annual general meeting to be held in 2012.

 

JPEL remains focused on maintaining a strong balance sheet. As such, the operation of the tender facility will be subject to various factors including positive distribution activity from the Company's underlying private equity investments and the overall health of the global economy. Therefore, JPEL's Board of Directors and the Manager will continue to monitor cash flows from JPEL's underlying investments in order to determine timing and appropriate levels for future tender offers. JPEL's Board of Directors continues to believe that its highest obligation during periods of economic uncertainty is to keep the Company healthy and strong for the future.

 

* * *

ENQUIRIES

 

J.P. Morgan Private Equity Limited 

Troy Duncan: Tel (Direct): +44 207 742 3032 (troy.duncan@jpmorgan.com)

Gregory Getschow: Tel (Direct): +1 212 648 1150 (gregrory.getschow@jpmorgan.com)

Rosemary DeRise: Tel (Direct): +1 212 648 2980 (rosemary.derise@jpmorgan.com)

Samantha Ladd: Tel (Direct): +1 212 648 2982 (samantha.ladd@jpmorgan.com)

 

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPEZ, JPZZ, JPSZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market. On 17 August 2009, JPEL issued warrants free of subscription cost to shareholders on record. The warrants are publicly traded on the London Stock Exchange under the symbol "JPWW."

 

END

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TENEANFEFDNFFEF
Date   Source Headline
28th Oct 20217:00 amRNSHolding(s) in Company
26th Oct 20214:03 pmRNSHolding(s) in Company
25th Oct 20215:52 pmRNSNet Asset Value - July 2021
30th Sep 20218:27 amRNSAnnual Financial Report - 30 June 2021
12th Aug 20217:00 amRNSCompletion of Ninth Mandatory Redemption
5th Aug 20217:00 amRNSNinth Mandatory Redemption
4th Aug 20213:45 pmRNSNet Asset Value - June 2021
23rd Jul 20213:52 pmRNSLargest Investment Sale & 9th Mandatory Redemption
21st Jul 20213:16 pmRNSNet Asset Value - May 2021
3rd Jun 20213:59 pmRNSNet Asset Value - April 2021
14th May 20213:52 pmRNSNet Asset Value - March 2021
19th Apr 20219:34 amRNSNet Asset Value - February 2021
6th Apr 20217:00 amRNSHolding(s) in Company
1st Apr 20214:21 pmRNSHolding(s) in Company
31st Mar 20215:17 pmRNSNet Asset Value - January 2021
17th Mar 20215:13 pmRNSHalf-year Report - 31 December 2020
24th Feb 20214:35 pmRNSNet Asset Value - December 2020
28th Jan 20215:27 pmRNSHolding(s) in Company
25th Jan 20214:49 pmRNSHolding(s) in Company
15th Jan 20212:01 pmRNSNet Asset Value - November 2020
14th Jan 20213:30 pmRNSHolding(s) in Company
30th Dec 20207:00 amRNSCompletion of 8th Mandatory Redemption
17th Dec 20207:00 amRNSLargest Investment & 8th Mandatory Redemption
11th Dec 20203:01 pmRNSNet Asset Value - October 2020
26th Nov 202010:43 amRNSAGM Results 2020
26th Nov 202010:16 amRNSAGM Results 2020
20th Nov 20207:00 amRNSNet Asset Value - September 2020
18th Nov 20207:00 amRNSStatement re Company Update
13th Nov 20202:49 pmRNSNet Asset Value - August 2020
9th Nov 20204:43 pmRNSNet Asset Value - July 2020
4th Nov 20209:35 amRNS2020 AGM CIRCULAR
8th Oct 20207:00 amRNSAnnual Financial Report - 30 June 2020
16th Sep 202011:55 amRNSNet Asset Value - June 2020
31st Jul 20203:05 pmRNSNet Asset Value - May 2020
24th Jun 20207:00 amRNSNet Asset Value - April 2020
10th Jun 202011:04 amRNSNet Asset Value - March 2020
24th Apr 20207:00 amRNSNet Asset Value - February 2020
14th Apr 20204:47 pmRNSNet Asset Value - January 2020
14th Apr 20203:35 pmRNSNet Asset Value - January 2020
14th Apr 20203:16 pmRNSHolding(s) in Company
1st Apr 20205:35 pmRNSReplacement Completion of 7th Mandatory Redemption
1st Apr 20203:33 pmRNSCompletion of Seventh Mandatory Redemption
25th Mar 20207:00 amRNSSeventh Mandatory Redemption
17th Mar 20203:46 pmRNSHalf-year Report - 31 December 2019
13th Mar 20207:00 amRNSPartial Sale of 2nd Largest Investment
6th Mar 20204:51 pmRNSNet Asset Value(s) - December 2019
10th Jan 20203:21 pmRNSNet Asset Value - November 2019
5th Dec 20194:56 pmRNSNet Asset Value(s) - October 2019
26th Nov 20197:00 amRNSAGM Results 2019
15th Nov 20196:23 pmRNSNet Asset Value(s) - September - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.